2025 February 12 • Discogen is sponsoring a First-In-Human clinical trial with principal investigator Dr. Clark Smith of the Columbia University Irving Medical Center’s Department of Rehabilitation and Regenerative Medicine. It will be a double-blinded, two-arm, prospective, randomized controlled pilot feasibility study. For more information, see our posting on ClinicalTrials.gov.
